ReP USP - Resultado da busca

Artigo de periodico
SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern (2024)
Hojo-Souza, Nathalia Satchiko ; Castro, Júlia T. de; Rivelli, Graziella Gomes ; Azevedo, Patrick Orestes de ; Oliveira, Emiliano Castro de ; Faustino, Lídia Paula ; Salazar, Natália; Bagno, Flávia Fonseca ; Carvalho, Alex F.; Rattis, Bruna Amanda da Cruz ; Lourenço, Karine Lima ; Gomes, Isabela P.; Assis, Bruna Rodrigues Dias; Piccin, Mariela Pires Cabral ; Fonseca, Flavio Guimarães da ; Souza, Renan Pedra de ; Goulart, Gisele Assis Castro ; Santiago, Helton da Costa ; Gazzinelli, Ricardo Tostes ; Silva, João Santana da ; Durigon, Edison Luiz
Source: Vaccine. Unidades: FMRP, ICB
Subjects: MICROBIOLOGIA, CAMUNDONGOS, HAMSTERS, PROTEÍNAS RECOMBINANTES, COVID-19, VACINAS VIRAIS, IMUNOGENICIDADE DA VACINA, IMUNIDADE, ADJUVANTES IMUNOLÓGICOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOJO-SOUZA, Nathalia Satchiko et al. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, v. 42, n. 26, p. 16 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2024.126394. Acesso em: 04 jan. 2025.
APA
Hojo-Souza, N. S., Castro, J. T. de, Rivelli, G. G., Azevedo, P. O. de, Oliveira, E. C. de, Faustino, L. P., et al. (2024). SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern. Vaccine, 42( 26), 16 . doi:10.1016/j.vaccine.2024.126394
NLM
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 jan. 04 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Vancouver
Hojo-Souza NS, Castro JT de, Rivelli GG, Azevedo PO de, Oliveira EC de, Faustino LP, Salazar N, Bagno FF, Carvalho AF, Rattis BA da C, Lourenço KL, Gomes IP, Assis BRD, Piccin MPC, Fonseca FG da, Souza RP de, Goulart GAC, Santiago H da C, Gazzinelli RT, Silva JS da, Durigon EL. SpiN-Tec: a T cell-based recombinant vaccine that is safe, immunogenic, and shows high efficacy in experimental models challenged with SARS-CoV-2 variants of concern [Internet]. Vaccine. 2024 ; 42( 26): 16 .[citado 2025 jan. 04 ] Available from: https://doi.org/10.1016/j.vaccine.2024.126394
Artigo de periodico
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein (2022)
Castro, Julia T.; Azevedo, Patrick; Fumagalli, Marcílio Jorge; Hojo-Souza, Natalia S.; Salazar, Natalia; Almeida, Gregório G.; Oliveira, Livia I.; Faustino, Lídia; Antonelli, Lis R.; Marçal, Tomas G.; Augusto, Marconi; Valiate, Bruno; Fiorini, Alex; Rattis, Bruna Amanda da Cruz; Ramos, Simone Gusmão; Piccin, Mariela Pires Cabral; Nonato, Osvaldo Campos dos Santos; Benevides, Luciana; Magalhães, Rubens; Cassaro, Bruno; Burle, Gabriela; Doro, Daniel; Kalil, Jorge; Durigon, Edison Luiz ; Salazar, Andrés; Caballero, Otávia; Santiago, Helton; Machado, Alexandre; Silva, João Santana da ; Fonseca, Flávio da; Fernandes, Ana Paula; Teixeira, Santuza R.; Gazzinelli, Ricardo Tostes
Source: Nature Communications. Unidades: FMRP, ICB
Subjects: ANTICORPOS, LINFÓCITOS T, VACINAS, COVID-19, GLICOPROTEÍNAS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Julia T. et al. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications, v. 13, n. 1, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-32547-y. Acesso em: 04 jan. 2025.
APA
Castro, J. T., Azevedo, P., Fumagalli, M. J., Hojo-Souza, N. S., Salazar, N., Almeida, G. G., et al. (2022). Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nature Communications, 13( 1), 1-16. doi:10.1038/s41467-022-32547-y
NLM
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis BA da C, Ramos SG, Piccin MPC, Nonato OC dos S, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon EL, Salazar A, Caballero O, Santiago H, Machado A, Silva JS da, Fonseca F da, Fernandes AP, Teixeira SR, Gazzinelli RT. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein [Internet]. Nature Communications. 2022 ; 13( 1): 1-16.[citado 2025 jan. 04 ] Available from: https://doi.org/10.1038/s41467-022-32547-y
Vancouver
Castro JT, Azevedo P, Fumagalli MJ, Hojo-Souza NS, Salazar N, Almeida GG, Oliveira LI, Faustino L, Antonelli LR, Marçal TG, Augusto M, Valiate B, Fiorini A, Rattis BA da C, Ramos SG, Piccin MPC, Nonato OC dos S, Benevides L, Magalhães R, Cassaro B, Burle G, Doro D, Kalil J, Durigon EL, Salazar A, Caballero O, Santiago H, Machado A, Silva JS da, Fonseca F da, Fernandes AP, Teixeira SR, Gazzinelli RT. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein [Internet]. Nature Communications. 2022 ; 13( 1): 1-16.[citado 2025 jan. 04 ] Available from: https://doi.org/10.1038/s41467-022-32547-y
Tese (Doutorado)
Efeito da curcumina na expressão dos componentes da via mTOR no coração de camundongos submetidos a sepse experimental (2022)
Rattis, Bruna Amanda da Cruz; Celes, Mara Rubia Nunes (Orientador)
Unidade: FMRP
Subjects: INSUFICIÊNCIA CARDÍACA, AÇAFRÃO, SEPSE, ANIMAIS DE LABORATÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATTIS, Bruna Amanda da Cruz. Efeito da curcumina na expressão dos componentes da via mTOR no coração de camundongos submetidos a sepse experimental. 2022. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2022. Disponível em: https://www.teses.usp.br/teses/disponiveis/17/17143/tde-13072022-152534/. Acesso em: 04 jan. 2025.
APA
Rattis, B. A. da C. (2022). Efeito da curcumina na expressão dos componentes da via mTOR no coração de camundongos submetidos a sepse experimental (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/17/17143/tde-13072022-152534/
NLM
Rattis BA da C. Efeito da curcumina na expressão dos componentes da via mTOR no coração de camundongos submetidos a sepse experimental [Internet]. 2022 ;[citado 2025 jan. 04 ] Available from: https://www.teses.usp.br/teses/disponiveis/17/17143/tde-13072022-152534/
Vancouver
Rattis BA da C. Efeito da curcumina na expressão dos componentes da via mTOR no coração de camundongos submetidos a sepse experimental [Internet]. 2022 ;[citado 2025 jan. 04 ] Available from: https://www.teses.usp.br/teses/disponiveis/17/17143/tde-13072022-152534/
Artigo de periodico
Impact of microbiota depletion by antibiotics on SARS-CoV-2 infection of K18-hACE2 mice (2022)
Rodrigues, Patrícia Brito; Gomes, Giovanni Freitas; Angelim, Monara K. S. C.; Souza, Gabriela F.; Muraro, Stéfanie Primon ; Toledo-Teixeira, Daniel A.; Rattis, Bruna Amanda da Cruz; Passos, Amanda Stephane Cruz dos; Pral, Laís Passariello ; Rodovalho, Vinícius de Rezende ; Gomes, Arilson Bernardo dos Santos P.; Matheus, Valquíria Aparecida ; Antunes, André Saraiva Leão Marcelo ; Crunfli, Fernanda ; Antunes, Krist Helen; Souza, Ana Paula Duarte de; Consonni, Sílvio Roberto ; Leiria, Luiz Osório Silveira ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Moraes-Vieira, Pedro Manoel Mendes de ; Modena, José Luiz Proenca ; Vinolo, Marco Aurelio Ramirez
Source: Cells. Unidade: FMRP
Subjects: COVID-19, MODELOS ANIMAIS DE DOENÇAS, QUIMIOTERÁPICOS, INFECÇÕES POR CORONAVIRUS, INFECÇÕES RESPIRATÓRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Patrícia Brito et al. Impact of microbiota depletion by antibiotics on SARS-CoV-2 infection of K18-hACE2 mice. Cells, v. 11, n. 16, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/cells11162572. Acesso em: 04 jan. 2025.
APA
Rodrigues, P. B., Gomes, G. F., Angelim, M. K. S. C., Souza, G. F., Muraro, S. P., Toledo-Teixeira, D. A., et al. (2022). Impact of microbiota depletion by antibiotics on SARS-CoV-2 infection of K18-hACE2 mice. Cells, 11( 16), 1-16. doi:10.3390/cells11162572
NLM
Rodrigues PB, Gomes GF, Angelim MKSC, Souza GF, Muraro SP, Toledo-Teixeira DA, Rattis BA da C, Passos ASC dos, Pral LP, Rodovalho V de R, Gomes AB dos SP, Matheus VA, Antunes ASLM, Crunfli F, Antunes KH, Souza APD de, Consonni SR, Leiria LOS, Alves Filho JCF, Cunha TM, Moraes-Vieira PMM de, Modena JLP, Vinolo MAR. Impact of microbiota depletion by antibiotics on SARS-CoV-2 infection of K18-hACE2 mice [Internet]. Cells. 2022 ; 11( 16): 1-16.[citado 2025 jan. 04 ] Available from: https://doi.org/10.3390/cells11162572
Vancouver
Rodrigues PB, Gomes GF, Angelim MKSC, Souza GF, Muraro SP, Toledo-Teixeira DA, Rattis BA da C, Passos ASC dos, Pral LP, Rodovalho V de R, Gomes AB dos SP, Matheus VA, Antunes ASLM, Crunfli F, Antunes KH, Souza APD de, Consonni SR, Leiria LOS, Alves Filho JCF, Cunha TM, Moraes-Vieira PMM de, Modena JLP, Vinolo MAR. Impact of microbiota depletion by antibiotics on SARS-CoV-2 infection of K18-hACE2 mice [Internet]. Cells. 2022 ; 11( 16): 1-16.[citado 2025 jan. 04 ] Available from: https://doi.org/10.3390/cells11162572
Artigo de periodico
Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts (2021)
Rattis, Bruna Amanda da Cruz; Freitas, Ana Caroline Silva de; Oliveira, Jordana F.; Calandrini-Lima, João L. A.; Figueiredo, Maria José; Soave, Danilo F.; Ramos, Simone Gusmão; Celes, Mara Rubia Nunes
Source: Oxidative Medicine and Cellular Longevity. Unidade: FMRP
Subjects: CANAIS DE CÁLCIO, SEPSE, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATTIS, Bruna Amanda da Cruz et al. Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts. Oxidative Medicine and Cellular Longevity, v. 2021, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.1155/2021/6667074. Acesso em: 04 jan. 2025.
APA
Rattis, B. A. da C., Freitas, A. C. S. de, Oliveira, J. F., Calandrini-Lima, J. L. A., Figueiredo, M. J., Soave, D. F., et al. (2021). Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts. Oxidative Medicine and Cellular Longevity, 2021, 1-8. doi:10.1155/2021/6667074
NLM
Rattis BA da C, Freitas ACS de, Oliveira JF, Calandrini-Lima JLA, Figueiredo MJ, Soave DF, Ramos SG, Celes MRN. Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts [Internet]. Oxidative Medicine and Cellular Longevity. 2021 ; 2021 1-8.[citado 2025 jan. 04 ] Available from: https://doi.org/10.1155/2021/6667074
Vancouver
Rattis BA da C, Freitas ACS de, Oliveira JF, Calandrini-Lima JLA, Figueiredo MJ, Soave DF, Ramos SG, Celes MRN. Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts [Internet]. Oxidative Medicine and Cellular Longevity. 2021 ; 2021 1-8.[citado 2025 jan. 04 ] Available from: https://doi.org/10.1155/2021/6667074
Artigo de periodico
Curcumin as a Potential Treatment for COVID-19 (2021)
Rattis, Bruna Amanda da Cruz; Ramos, Simone Gusmão ; Celes, Mara Rubia Nunes
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: COVID-19, DOENÇAS INFECCIOSAS, AÇAFRÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATTIS, Bruna Amanda da Cruz e RAMOS, Simone Gusmão e CELES, Mara Rubia Nunes. Curcumin as a Potential Treatment for COVID-19. Frontiers in Pharmacology, v. 12, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.675287. Acesso em: 04 jan. 2025.
APA
Rattis, B. A. da C., Ramos, S. G., & Celes, M. R. N. (2021). Curcumin as a Potential Treatment for COVID-19. Frontiers in Pharmacology, 12, 1-14. doi:10.3389/fphar.2021.675287
NLM
Rattis BA da C, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19 [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-14.[citado 2025 jan. 04 ] Available from: https://doi.org/10.3389/fphar.2021.675287
Vancouver
Rattis BA da C, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19 [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-14.[citado 2025 jan. 04 ] Available from: https://doi.org/10.3389/fphar.2021.675287
Artigo de periodico
ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients (2021)
Ramos, Simone Gusmão; Rattis, Bruna Amanda da Cruz; Ottaviani, Giulia; Celes, Mara Rubia Nunes ; Dias, Eliane Pedra
Source: The American Journal of Pathology. Unidade: FMRP
Subjects: ANGIOTENSINA II, COVID-19, MICROCIRCULAÇÃO, SISTEMA RENINA-ANGIOTENSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Simone Gusmão et al. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients. The American Journal of Pathology, v. 191, n. 7, p. 1154-1164, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ajpath.2021.04.010. Acesso em: 04 jan. 2025.
APA
Ramos, S. G., Rattis, B. A. da C., Ottaviani, G., Celes, M. R. N., & Dias, E. P. (2021). ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients. The American Journal of Pathology, 191( 7), 1154-1164. doi:10.1016/j.ajpath.2021.04.010
NLM
Ramos SG, Rattis BA da C, Ottaviani G, Celes MRN, Dias EP. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients [Internet]. The American Journal of Pathology. 2021 ; 191( 7): 1154-1164.[citado 2025 jan. 04 ] Available from: https://doi.org/10.1016/j.ajpath.2021.04.010
Vancouver
Ramos SG, Rattis BA da C, Ottaviani G, Celes MRN, Dias EP. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients [Internet]. The American Journal of Pathology. 2021 ; 191( 7): 1154-1164.[citado 2025 jan. 04 ] Available from: https://doi.org/10.1016/j.ajpath.2021.04.010

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation